Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Completed

Conditions studied: Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma

In brief

This research trial studies biomarkers in patients with previously untreated invasive ovarian epithelial, fallopian tube, or primary peritoneal cancer. Studying samples of tumor tissue, peritoneal cavity fluid, and blood from patients receiving chemotherapy directly into the abdominal cavity (intraperitoneal) may help doctors learn more about the effects of intraperitoneal chemotherapy on cells. It may also help doctors identify and learn more about biomarkers related to cancer.

Key facts

Study ID

NCT01295489

Run by

Gynecologic Oncology Group

People needed

39

Starts

2011-03-01

Last updated by the study team

2018-05-22

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be enrolled on GOG-0252
• Patients must have an IP catheter placed prior to initiating platinum and taxane-based chemotherapy on GOG-0252
• Patients must have signed an approved informed consent for specimen collection and participation in this translational research study

You may not qualify if…

• Patients who are not enrolled on GOG-0252
• Patients who have not had an IP catheter placed prior to initiating platinum and taxane-based IP chemotherapy on GOG-0252
• Patients who did not sign an approved informed consent for specimen collection and participation in this translational research study

Where it is running

• Sudarshan K Sharma MD Limted-Gynecologic Oncology — Hinsdale, Illinois, United States
• Memorial Medical Center — Springfield, Illinois, United States
• McFarland Clinic PC-William R Bliss Cancer Center — Ames, Iowa, United States
• Billings Clinic Cancer Center — Billings, Montana, United States
• Roswell Park Cancer Institute — Buffalo, New York, United States
• Riverside Methodist Hospital — Columbus, Ohio, United States
• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States
• Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma, United States
• Women and Infants Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.